Synergism between platelet activating factor and C-C chemokines for arachidonate release in human monocytes

Biochem Biophys Res Commun. 1994 Mar 15;199(2):761-6. doi: 10.1006/bbrc.1994.1294.

Abstract

Monocyte Chemotactic Protein(MCP)-1 and other members of the C-C branch of the chemokine superfamily (RANTES, MIP1 alpha/LD78, and MCP-3) induced, at chemotactic concentrations, the release of [3H]arachidonic acid in prelabeled human monocytes. Arachidonate release was potentiated (2 to 4 fold) in the presence of platelet activating factor (PAF). PAF effect was blocked by a specific receptor antagonist, WEB 2187, and was not present when inactive analogs, PAF inactive enantiomer, or lysoPAF were used. Thus, the synergistic action of PAF with C-C chemokines, in terms of arachidonate release and chemotaxis, is specific for this alkylphospholipid and is receptor mediated. Reciprocal potentiation of PAF and C-C chemokines may be important at sites of inflammation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arachidonic Acid / blood*
  • Chemokine CCL2
  • Chemokine CCL4
  • Chemokine CCL5
  • Chemokine CCL7
  • Chemotactic Factors / pharmacology
  • Chemotaxis, Leukocyte / drug effects*
  • Cytokines / pharmacology*
  • Drug Synergism
  • Humans
  • In Vitro Techniques
  • Kinetics
  • Lymphokines / pharmacology
  • Macrophage Inflammatory Proteins
  • Monocyte Chemoattractant Proteins*
  • Monokines / pharmacology
  • Platelet Activating Factor / pharmacology*

Substances

  • CCL7 protein, human
  • Chemokine CCL2
  • Chemokine CCL4
  • Chemokine CCL5
  • Chemokine CCL7
  • Chemotactic Factors
  • Cytokines
  • Lymphokines
  • Macrophage Inflammatory Proteins
  • Monocyte Chemoattractant Proteins
  • Monokines
  • Platelet Activating Factor
  • Arachidonic Acid